Strategies for Treating Alzheimer’s: Current Approaches and Future Perspectives
DOI:
https://doi.org/10.12775/QS.2025.41.58829Keywords
Alzheimer's disease, amyloid, tau, inflammation, dementia, acetylcho, acetylcholinesterase inhibitors, gene therapyAbstract
Introduction and Purpose:
Alzheimer’s disease is the most common cause of dementia, affecting millions of people worldwide and posing a significant challenge to modern medicine. This review explores the available treatment options, their limitations, and the future directions of research that may bring breakthroughs in combating this devastating condition.
Materials and Methods:
This article is a comprehensive review based on a detailed analysis of peer-reviewed studies obtained from major scientific databases, such as PubMed. The selected articles focus on modern methods of treating Alzheimer’s disease, chosen for their relevance and importance to the subject.
Results:
This review highlights the complex pathogenesis of Alzheimer’s disease (AD), driven by amyloid-β accumulation, tau protein abnormalities, cholinergic deficits, and neuroinflammation. Current treatments, such as cholinesterase inhibitors and NMDA receptor antagonists, provide only temporary symptom relief, while emerging therapies, including immunotherapy and gene therapy, offer promising new directions. Advances in disease-modifying approaches targeting Aβ, tau, and genetic factors have shown potential, though challenges remain in achieving long-term efficacy and accessibility.
Conclusion:
Despite significant progress in understanding AD and developing new treatment strategies, an effective cure remains elusive. Immunotherapies and gene therapy represent promising avenues for disease modification, but further research is needed to optimize their effectiveness and accessibility. A multidisciplinary approach combining pharmacological, genetic, and lifestyle interventions is essential to improving patient outcomes and combating this devastating disease.
References
1. Kumar A, Sidhu J, Lui F, Tsao JW. Alzheimer Disease. In: StatPearls. Treasure Island (FL): StatPearls Publishing; February 12, 2024.
2. 2021 Alzheimer's disease facts and figures. Alzheimers Dement. 2021;17(3):327-406. doi:10.1002/alz.12328
3. Rostagno AA. Pathogenesis of Alzheimer's Disease. Int J Mol Sci. 2022;24(1):107. Published 2022 Dec 21. doi:10.3390/ijms24010107
4. Shokri-Kojori E, Wang GJ, Wiers CE, et al. β-Amyloid accumulation in the human brain after one night of sleep deprivation. Proc Natl Acad Sci U S A. 2018;115(17):4483-4488. doi:10.1073/pnas.1721694115
5. Brett BL, Gardner RC, Godbout J, Dams-O'Connor K, Keene CD. Traumatic Brain Injury and Risk of Neurodegenerative Disorder. Biol Psychiatry. 2022;91(5):498-507. doi:10.1016/j.biopsych.2021.05.025
6. Yarns BC, Holiday KA, Carlson DM, Cosgrove CK, Melrose RJ. Pathophysiology of Alzheimer's Disease. Psychiatr Clin North Am. 2022;45(4):663-676. doi:10.1016/j.psc.2022.07.003
7. Hampel H, Hardy J, Blennow K, et al. The Amyloid-β Pathway in Alzheimer's Disease. Mol Psychiatry. 2021;26(10):5481-5503. doi:10.1038/s41380-021-01249-0
8. Chen Y, Yu Y. Tau and neuroinflammation in Alzheimer's disease: interplay mechanisms and clinical translation. J Neuroinflammation. 2023;20(1):165. Published 2023 Jul 14. doi:10.1186/s12974-023-02853-3
9. Hampel H, Mesulam MM, Cuello AC, et al. The cholinergic system in the pathophysiology and treatment of Alzheimer's disease. Brain. 2018;141(7):1917-1933. doi:10.1093/brain/awy132
10. Li Y, Wang R, Li Q, Wang YJ, Guo J. Gut Microbiota and Alzheimer's Disease: Pathophysiology and Therapeutic Perspectives. J Alzheimers Dis. 2021;83(3):963-976. doi:10.3233/JAD-210381
11. Bent-Ennakhil N, Coste F, Xie L, et al. A Real-world Analysis of Treatment Patterns for Cholinesterase Inhibitors and Memantine among Newly-diagnosed Alzheimer's Disease Patients. Neurol Ther. 2017;6(1):131-144. doi:10.1007/s40120-017-0067-7
12. Winblad B, Graf A, Riviere ME, Andreasen N, Ryan JM. Active immunotherapy options for Alzheimer's disease. Alzheimers Res Ther. 2014;6(1):7. Published 2014 Jan 30. doi:10.1186/alzrt237
13. Song C, Shi J, Zhang P, et al. Immunotherapy for Alzheimer's disease: targeting β-amyloid and beyond. Transl Neurodegener. 2022;11(1):18. Published 2022 Mar 18. doi:10.1186/s40035-022-00292-3
14. Guo X, Yan L, Zhang D, Zhao Y. Passive immunotherapy for Alzheimer's disease. Ageing Res Rev. 2024;94:102192. doi:10.1016/j.arr.2024.102192
15. Budd Haeberlein S, Aisen PS, Barkhof F, et al. Two Randomized Phase 3 Studies of Aducanumab in Early Alzheimer's Disease. J Prev Alzheimers Dis. 2022;9(2):197-210. doi:10.14283/jpad.2022.30
16. Congdon EE, Ji C, Tetlow AM, Jiang Y, Sigurdsson EM. Tau-targeting therapies for Alzheimer disease: current status and future directions. Nat Rev Neurol. 2023;19(12):715-736. doi:10.1038/s41582-023-00883-2
17. Parrocha CMT, Nowick JS. Current Peptide Vaccine and Immunotherapy Approaches Against Alzheimer's Disease. Pept Sci (Hoboken). 2023;115(1):e24289. doi:10.1002/pep2.24289
18. Khan S, Barve KH, Kumar MS. Recent Advancements in Pathogenesis, Diagnostics and Treatment of Alzheimer's Disease. Curr Neuropharmacol. 2020;18(11):1106-1125. doi:10.2174/1570159X18666200528142429
19. Weninger S, Sperling B, Alexander R, et al. Active immunotherapy and alternative therapeutic modalities for Alzheimer's disease. Alzheimers Dement (N Y). 2020;6(1):e12090. Published 2020 Oct 12. doi:10.1002/trc2.12090
20. Serrano-Pozo A, Das S, Hyman BT. APOE and Alzheimer's disease: advances in genetics, pathophysiology, and therapeutic approaches [published correction appears in Lancet Neurol. 2021 Feb;20(2):e2. doi: 10.1016/S1474-4422(21)00004-1.]. Lancet Neurol. 2021;20(1):68-80. doi:10.1016/S1474-4422(20)30412-9
21. Raikwar SP, Thangavel R, Dubova I, et al. Neuro-Immuno-Gene- and Genome-Editing-Therapy for Alzheimer's Disease: Are We There Yet?. J Alzheimers Dis. 2018;65(2):321-344. doi:10.3233/JAD-180422
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 Adriana Skuba, Katarzyna Załuska, Agnieszka Świdniak, Marta Biskup, Aleksandra Bartoszek, Karolina Kopeć, Agnieszka Marut, Jagoda Misiuk, Julia Adamiuk, Sylwia Nykiel

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Stats
Number of views and downloads: 137
Number of citations: 0